Substance / Medication

Guanidine hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
The management of Lambert Eaton syndrome in the setting of hypertensive disorders of pregnancy: A literature review.
Friedlich Nicole, Slear Elizabeth, Faszholz Alicia et al. · Pregnancy Hypertens · 2025
PMID: 40946449Meta-Analysis
Treatment for Lambert-Eaton myasthenic syndrome.
Keogh Michael, Sedehizadeh Saam, Maddison Paul · Cochrane Database Syst Rev · 2011
PMID: 21328260Meta-AnalysisFull text (PMC)
Treatment for Lambert-Eaton myasthenic syndrome.
Maddison P, Newsom-Davis J · Cochrane Database Syst Rev · 2005
PMID: 15846654Meta-Analysis
Treatment for Lambert-Eaton myasthenic syndrome.
Maddison P, Newsom-Davis J · Cochrane Database Syst Rev · 2003
PMID: 12804456Meta-Analysis
3,4-diaminopyridine base effectively treats the weakness of Lambert-Eaton myasthenia.
Sanders Donald B, Juel Vern C, Harati Yadollah et al. · Muscle Nerve · 2018
PMID: 29280483RCTFull text (PMC)
The recognition, physiology, and treatment of Lambert-Eaton myasthenic syndrome.
Randall David P · Dis Mon · 2025
PMID: 40544116Review
Lambert Eaton Myasthenic Syndrome.
El-Wahsh Shadi, Reddel Stephen · Int Rev Neurobiol · 2025
PMID: 40675738Review
[Blood-brain barrier breakdown and autoimmune cerebellar ataxia].
Shimizu Fumitaka · Rinsho Shinkeigaku · 2024
PMID: 38403685Review

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Guanidine hydrochloride (substance)
SNOMED CT
412195000
UMLS CUI
C0120447

Clinical Data

This intervention maps to 1 entities in the Ltrl knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.